1. Saturday, November 5, 2016  Evaluation

Question Title

* 1. Please provide your name and License #

General Sessions  - 8:00 am - 11:35 am

Question Title

* 2. Multidisciplinary Teams and Interdisciplinary Ethics

  1 (lowest) 2 3 4 5 (highest)
Activity Met My Learning Objectives
Effectiveness of the Speaker
Relevance of Content to Objectives
Session Met My Personal Objectives
Physical Environment Conducive to Learning
Presentation was free of bias Y/N (if no, explain)

Question Title

* 3. Please provide any comments you have regarding the Speaker, F. Daniel Davis, PhD

Question Title

* 4. Best Practices in the Use of Incretin-Based Therapies in the Management of Type 2 Diabetes

  1 (lowest) 2 3 4 5 (highest)
Activity Met My Learning Objectives
Effectiveness of the Speaker
Relevance of Content to Objectives
Session Met My Personal Objectives
Physical Environment Conducive to Learning
Presentation was free of bias Y/N (if no, explain)

Question Title

* 5. Please provide any comments you have regarding the Speaker, Frances Sahebamani, NP

Question Title

* 6. Put Your Liability IQ to the Test: To Reasons NPs Get Sued

  1 (lowest) 2 3 4 5 (highest)
Activity Met My Learning Objectives
Effectiveness of the Speaker
Relevance of Content to Objectives
Session Met My Personal Objectives
Physical Environment Conducive to Learning
Presentation was free of bias Y/N (if no, explain)

Question Title

* 7. Please provide any comments you have regarding the Speaker, Michael Loughran, NSO President

Concurrent Sessions 4 - 1:30 pm - 2:30 pm

Question Title

* 8. #401 (Sexually Transmitted Infections: Update on Screening, Testing and Treatment Guidelines)

  1 (lowest) 2 3 4 5 (highest)
Activity Met My Learning Objectives
Effectiveness of the Speaker
Relevance of Content to Objectives
Session Met My Personal Objectives
Physical Environment Conducive to Learning
Presentation was free of bias Y/N (if no, explain)

Question Title

* 9. Please provide any comments you have regarding the Speaker, Brenda Cassidy, DNP, RN, CPNP-PC

Question Title

* 10. #402 (The Fault in Our Stars: End of Life Care for the Critically Ill)

  1 (lowest) 2 3 4 5 (highest)
Activity Met My Learning Objectives
Effectiveness of the Speaker
Relevance of Content to Objectives
Session Met My Personal Objectives
Physical Environment Conducive to Learning
Presentation was free of bias Y/N (if no, explain)

Question Title

* 11. Please provide any comments you have regarding the Speaker, Patricia Maani-Fogelman, DNP

Question Title

* 12. Please provide any comments you have regarding the Speaker, Sally Regel, MSN, CRNP

Question Title

* 13. #403 (Emerging Therapies for the Reversal of Anticoagulation)

  1 (lowest) 2 3 4 5 (highest)
Activity Met My Learning Objectives
Effectiveness of the Speaker
Relevance of Content to Objectives
Session Met My Personal Objectives
Physical Environment Conducive to Learning
Presentation was free of bias Y/N (if no, explain)

Question Title

* 14. Please provide any comments you have regarding the Speaker, Angela Slampak-Cindric, Pharm D, BCPS

Question Title

* 15. #404 (ADHD in Adults: The Role of the NP)

  1 (lowest) 2 3 4 5 (highest)
Activity Met My Learning Objectives
Effectiveness of the Speaker
Relevance of Content to Objectives
Session Met My Personal Objectives
Physical Environment Conducive to Learning
Presentation was free of bias Y/N (if no, explain)

Question Title

* 16. Please provide any comments you have regarding the Speaker, Kirstyn Kameg, DNP, PMHNP-BC

Question Title

* 17. #405 (Opioid Use Disorder: Looking Forward)

  1 (lowest) 2 3 4 5 (highest)
Activity Met My Learning Objectives
Effectiveness of the Speaker
Relevance of Content to Objectives
Session Met My Personal Objectives
Physical Environment Conducive to Learning
Presentation was free of bias Y/N (if no, explain)

Question Title

* 18. Please provide any comments you have regarding the Speaker, Gail Kaempf, MSN, CRNP

Question Title

* 19. #406 (New Beginnings: Tips for Helping Nurse Practitioners Find the Best Position)

  1 (lowest) 2 3 4 5 (highest)
Activity Met My Learning Objectives
Effectiveness of the Speaker
Relevance of Content to Objectives
Session Met My Personal Objectives
Physical Environment Conducive to Learning
Presentation was free of bias Y/N (if no, explain)

Question Title

* 20. Please provide any comments you have regarding the Speaker, Lori Martin Plank, PhD, FNP-C, GNP-BC, FAANP, FNAP

Question Title

* 21. Please provide any comments you have regarding the Speaker, Lois Chappell, MSN, CRNP

Concurrent Sessions 5 - 2:45 pm - 3:45 pm

Question Title

* 22. #501 (Familial Hypercholesterolemia: Under-Recognized, Under-Treated, New-Novel Therapies)

  1 (lowest) 2 3 4 5 (highest)
Activity Met My Learning Objectives
Effectiveness of the Speaker
Relevance of Content to Objectives
Session Met My Personal Objectives
Physical Environment Conducive to Learning
Presentation was free of bias Y/N (if no, explain)

Question Title

* 23. Please provide any comments you have regarding the Speaker, Caroline Graham, MSN, CRNP, ANP-BC

Question Title

* 24. #502 (Safe & Effective Prescribing of Analgesics)

  1 (lowest) 2 3 4 5 (highest)
Activity Met My Learning Objectives
Effectiveness of the Speaker
Relevance of Content to Objectives
Session Met My Personal Objectives
Physical Environment Conducive to Learning
Presentation was free of bias Y/N (if no, explain)

Question Title

* 25. Please provide any comments you have regarding the Speaker, Mary Jo Cerepani, DNP, FNP-BC, CEN

Question Title

* 26. Please provide any comments you have regarding the Speaker, Patricia Gilliam, PhD, ANP-BC

Question Title

* 27. #503 (Management of Acute Neurological Change in the ICU/ED Setting)

  1 (lowest) 2 3 4 5 (highest)
Activity Met My Learning Objectives
Effectiveness of the Speaker
Relevance of Content to Objectives
Session Met My Personal Objectives
Physical Environment Conducive to Learning
Presentation was free of bias Y/N (if no, explain)

Question Title

* 28. Please provide any comments you have regarding the Speaker, Timothy Rausch, FNP-BC

Question Title

* 29. #504 (Depression and Anxiety with Concurrent PTSD)

  1 (lowest) 2 3 4 5 (highest)
Activity Met My Learning Objectives
Effectiveness of the Speaker
Relevance of Content to Objectives
Session Met My Personal Objectives
Physical Environment Conducive to Learning
Presentation was free of bias Y/N (if no, explain)

Question Title

* 30. Please provide any comments you have regarding the Speaker, Megan Walsh, CRNP

Question Title

* 31. #505 (Radiation Oncology: An Overview)

  1 (lowest) 2 3 4 5 (highest)
Activity Met My Learning Objectives
Effectiveness of the Speaker
Relevance of Content to Objectives
Session Met My Personal Objectives
Physical Environment Conducive to Learning
Presentation was free of bias Y/N (if no, explain)

Question Title

* 32. Please provide any comments you have regarding the Speaker, Erin Davis, MSN, CRNP

Question Title

* 33. #506 (Panel: To DNP or Not to DNP)

  1 (lowest) 2 3 4 5 (highest)
Activity Met My Learning Objectives
Effectiveness of the Speaker
Relevance of Content to Objectives
Session Met My Personal Objectives
Physical Environment Conducive to Learning
Presentation was free of bias Y/N (if no, explain)

Question Title

* 34. Please provide any comments you have regarding the Speaker, Karen Anne Wolf, PhD, CRNP

Question Title

* 35. Please provide any comments you have regarding the Speaker, Geraldine M Budd, RN, CRNP, FNP-BC, FAANP

Question Title

* 36. Thank you for completing the survey - we greatly appreciate your feedback!

Your CE certificate will not populate upon completion of the survey.  You are required to complete the Attestation form, provided in your conference packet, and turn it in at the registration desk before you leave the conference.

Once you complete the surveys and attestation form, your AANP CE certificate will be emailed to you within three weeks

T